Alexa, Amazon’s digital shopping assistant, might want to be your drugstore, too: Amazon reportedly has obtained pharmacy licenses in a handful of states, hinting at possible plans to disrupt both the drugstore business and the larger healthcare industry.
According to the CNBC, the e-commerce giant has received wholesale pharmacy licenses in at least 12 states: Alabama, Arizona, Connecticut, Idaho, Louisiana, Michigan, Nevada, New Hampshire, New Jersey, North Dakota, Oregon, and Tennessee. Some states require the permits to sell “professional use only” medical devices to medical and dental practices such as procedure trays, sutures, and syringes.
Amazon’s potential entry into the pharmaceutical business spurred drug store and pharmaceutical benefits manager CVS to make a US$66 billion offer for health insurer Aetna, according to the Wall Street Journal. As the Journal noted, most prescriptions are filled in bricks-and-mortar pharmacies, though patients with chronic conditions are encouraged by insurers to get their medications through mail-order dispensaries.
According to CNBC, Amazon expects to decide by Thanksgiving whether it will begin selling prescription drugs online. Morningstar analyst Vishnu Lekraj, however, is skeptical about reports linking Amazon to the business of selling medications.
Full Content: CNBC
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
FTC and State Attorneys General Sue John Deere Over Repair Restrictions in Antitrust Case
Jan 15, 2025 by
CPI
Enbridge Wins Legal Battle Against Ducere’s Antitrust Allegations
Jan 15, 2025 by
CPI
GOP Pushes for Antitrust Authority Consolidation Under DOJ in New Legislation
Jan 15, 2025 by
CPI
Canadian Government Approves Bunge-Viterra Merger with Conditions
Jan 15, 2025 by
CPI
SEC Sues Elon Musk Over Delayed Disclosure of Twitter Stock Ownership
Jan 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – CRESSE Insights
Dec 19, 2024 by
CPI
Effective Interoperability in Mobile Ecosystems: EU Competition Law Versus Regulation
Dec 19, 2024 by
Giuseppe Colangelo
The Use of Empirical Evidence in Antitrust: Trends, Challenges, and a Path Forward
Dec 19, 2024 by
Eliana Garces
Some Empirical Evidence on the Role of Presumptions and Evidentiary Standards on Antitrust (Under)Enforcement: Is the EC’s New Communication on Art.102 in the Right Direction?
Dec 19, 2024 by
Yannis Katsoulacos
The EC’s Draft Guidelines on the Application of Article 102 TFEU: An Economic Perspective
Dec 19, 2024 by
Benoit Durand